Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars ØStergaard

Showing results (251-260 of 279) with videos related to

Pageof 28
Sort By:
Bioresource Technology|February 24, 2010
Polymerization of lignosulfonates by the laccase-HBT (1-hydroxybenzotriazole) system improves dispersibilityEndry Nugroho Prasetyo, Tukayi Kudanga, Lars Østergaard, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2003
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivoSerhat Erbayraktar, Giovanni Grasso, Alessandra Sfacteria, et al.
Immunity, Inflammation and Disease|March 12, 2026
Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With InfluenzaSara Bohnstedt Mørup, Maja Milojevic, Seyed Mahmood Taghavi Shahri, et al.
Plos One|February 23, 2011
Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and ArgentinaGerard A J Morris, Digna R Velez Edwards, Philip C Hill, et al.
The Plant Cell|July 1, 2025
Developmental pathways in plants: Lessons from Arabidopsis for crop innovationMalcolm J Bennett, Rahul Bhosale, Scott A Boden, et al.
The Journal of Infectious Diseases|April 30, 2024
Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and InfectionAnna Karina Juhl, Lisa Loksø Dietz, Ole Schmeltz Søgaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine Vibholm, Mariane H Schleimann, Jesper F Højen, et al.
The Lancet. Microbe|May 11, 2022
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trialHenning Gruell, Jesper D Gunst, Yehuda Z Cohen, et al.
Nature Communications|August 1, 2022
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infectionsNina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, et al.
Cell Reports|December 16, 2020
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral ReboundRasmus Offersen, Wen-Han Yu, Eileen P Scully, et al.
Pageof 28

Showing results (251-260 of 279) with videos related to

Sort By:
Pageof 28
Bioresource Technology|February 24, 2010
Polymerization of lignosulfonates by the laccase-HBT (1-hydroxybenzotriazole) system improves dispersibilityEndry Nugroho Prasetyo, Tukayi Kudanga, Lars Østergaard, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2003
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivoSerhat Erbayraktar, Giovanni Grasso, Alessandra Sfacteria, et al.
Immunity, Inflammation and Disease|March 12, 2026
Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With InfluenzaSara Bohnstedt Mørup, Maja Milojevic, Seyed Mahmood Taghavi Shahri, et al.
Plos One|February 23, 2011
Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and ArgentinaGerard A J Morris, Digna R Velez Edwards, Philip C Hill, et al.
The Plant Cell|July 1, 2025
Developmental pathways in plants: Lessons from Arabidopsis for crop innovationMalcolm J Bennett, Rahul Bhosale, Scott A Boden, et al.
The Journal of Infectious Diseases|April 30, 2024
Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and InfectionAnna Karina Juhl, Lisa Loksø Dietz, Ole Schmeltz Søgaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine Vibholm, Mariane H Schleimann, Jesper F Højen, et al.
The Lancet. Microbe|May 11, 2022
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trialHenning Gruell, Jesper D Gunst, Yehuda Z Cohen, et al.
Nature Communications|August 1, 2022
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infectionsNina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, et al.
Cell Reports|December 16, 2020
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral ReboundRasmus Offersen, Wen-Han Yu, Eileen P Scully, et al.
Pageof 28